Literature DB >> 21905033

Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.

Carmelo Puglia1, Francesco Bonina, Luisa Rizza, Paolo Blasi, Aurelie Schoubben, Rosario Perrotta, Maria Stella Tarico, Elisabetta Damiani.   

Abstract

The aim of the present study was the evaluation of lipid nanoparticles (solid lipid nanoparticles, SLN, and nanostructured lipid carriers, NLC) as potential carriers for octyl-methoxycinnamate (OMC). The release pattern of OMC from SLN and NLC was evaluated in vitro, determining its percutaneous absorption through excised human skin. Additional in vitro studies were performed in order to evaluate, after UVA radiation treatment, the spectral stability of OMC-loaded lipid nanoparticles. From the obtained results, ultrasonication method yielded both SLN and NLC in the nanometer range with a high active loading and a particle shape close to spherical. Differential scanning calorimetry data pointed out the key role of the inner oil phase of NLC in stabilizing the particle architecture and in increasing the solubility of OMC as compared with SLN. In vitro results showed that OMC, when incorporated in viscosized NLC dispersions (OMC-NLC), exhibited a lower flux with respect to viscosized SLN dispersions (OMC-SLN) and two reference formulations: a microemulsion (OMC-ME) and a hydroalcoholic gel (OMC-GEL). Photostability studies revealed that viscosized NLC dispersions were the most efficient at preserving OMC from ultraviolet-mediated photodegradation.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905033     DOI: 10.1002/jps.22741

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.

Authors:  Yin-Ku Lin; Saleh A Al-Suwayeh; Yann-Lii Leu; Feng-Ming Shen; Jia-You Fang
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

2.  Prevention of UVA-induced oxidative damage in human dermal fibroblasts by new UV filters, assessed using a novel in vitro experimental system.

Authors:  Francesca Brugè; Luca Tiano; Paola Astolfi; Monica Emanuelli; Elisabetta Damiani
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

3.  Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.

Authors:  Debora Santonocito; Giuseppina Raciti; Agata Campisi; Giovanni Sposito; Annamaria Panico; Edy Angela Siciliano; Maria Grazia Sarpietro; Elisabetta Damiani; Carmelo Puglia
Journal:  Nanomaterials (Basel)       Date:  2021-02-03       Impact factor: 5.076

Review 4.  Lipid Nanomaterials for Targeted Delivery of Dermocosmetic Ingredients: Advances in Photoprotection and Skin Anti-Aging.

Authors:  Eliana B Souto; Eliézer Jäger; Alessandro Jäger; Petr Štěpánek; Amanda Cano; Cesar Viseras; Raquel de Melo Barbosa; Marlus Chorilli; Aleksandra Zielińska; Patricia Severino; Beatriz C Naveros
Journal:  Nanomaterials (Basel)       Date:  2022-01-24       Impact factor: 5.076

5.  On line kinetic analysis of permeation profiles for UV filter loaded microemulsions using an automatic system with spectroscopic detection and a chemometric approach.

Authors:  Danielle Silva do Nascimento; Verónica Volpe; Matías Insausti; Marcos Grünhut
Journal:  RSC Adv       Date:  2021-04-26       Impact factor: 4.036

6.  Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.

Authors:  Cong Zhang; Fan Peng; Wei Liu; Jiangling Wan; Chunxi Wan; Huibi Xu; Christopher Waikei Lam; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2014-02-20

Review 7.  Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.

Authors:  Mohamed Haider; Shifaa M Abdin; Leena Kamal; Gorka Orive
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.